Member Info for beinthelead

Apologies - I’ve interacted and taken a positive thread down the regular deramper path.

If you left for your own mental health issues, for which I sympathise. Have some compassion for those you may be inflicting the same issues.

Subtle sell now messages, backed up by half truths. It’s not cool.

It is a deramp unfortunately.

Nobody said the connection would be exclusive.

Could be a master stroke.

There is no requirement for antibody tests to be ‘convenient’, or indeed rapid, given they provide 3 month grace as part of the passport. Nor volume for the same reason. Therefore, they will not use this production for sustained antibody test production.

Interesting to watch this one play out. Without doubt they’ll use their capacity to make money. And why not use it for their mutually beneficial tie up (shareholding & diet deal) with Avacta? So many tax/profit sharing benefits.

There’s confidence leading into this week.

AS stating ‘we will deliver’ in the recent Vox interview.

Inviting the analyst in to get first dibs on the new future post LFT data. Mega revenue forecasts.

Offering yourself up to existing investors for a Q&A.

If the LFT news is not available to exclaim by Thursday, why create this platform? There’s arrogance, and there’s plain unadvised stupidity.

Exactly unprecedented. It’s a framework tender that gives HMG access to as many companies as possible over the next few years of the Biotech boom.

A framework to support the industry they have already created with Avacta, Mologic, GAD, Abingdon and ODX.

Fair concern.

The good thing with Thursday being given as a comm’s date, it gives people the chance to sell and confirm profits. And no news by Tuesday, those fearing the worst should sell.

Tim - no, I get that. It was wyn’s comments around sell now while you have the opportunity... no offence by the way. I think that it adds pressure when in reality, it’s a momentary market force that will pass.

The subtle ‘sell all you have’ messages are out of order. These seemingly passive comments are directed to add doubt.

This is a high risk, high reward share. You’ll be able to sell outside of any turbulent periods. And there’s loads of opportunity to do it. Turbulent periods are to be held through. When it drops ala vaccine gate, tough luck. Nothing going to help.

Sell or hang around. The psychotic merry go round of charts and generalised share price activity is such a waste.

We’re all frustrated with the delays.

They’re going to come in for flack. It’s obvious.

But their criticism does not discount LFT’s. It discounts the current product they’re reviewing. They need a FFP product to deliver the strategy.

It’s all about requirements.

Requirement: Control and limit the spread of the virus using rapid test kits, suitable for use by the layman.

PCR testing is used to confirm the presence of the virus. It’s does that superbly well.

LFT’s provide away of screening a population to detect infectious individuals and prevent them from mixing with the herd.

Which equipment should we use to meet the requirement?

And they key point that most aren’t connecting, is the misuse of the tests. I.e NP used as AN or even NT. no wonder they aren’t accurate.

If used correctly, I’m convinced Innova has/had a place. But the future market wants simple, repeatable, home use kits. Any we have the only valid and credible test.

PJ - the frustration is there for us all. You either believe in the test, or you don’t.

If you don’t, best to sell now before it slides further.

Didn’t think it could go any lower...

Matt, never come back mate.

Big demand for tests doesn’t mean an abundant supply of positive samples.

We don’t know what the delay is, it’s only assumed. Time will tell. But we’re not likely to find out. And to be honest, I’m not that fussed.

Seeing the data presented as an entree to a sovereign test declaration will help me forget the limbo.

This.

Everybody zoom out. Shares go up, they go down. More so on AIM. You’re invested in high risk reward stock, with news to land any day/time.

This board makes people focus on the minute-by-minute performance of the share. Switch off until the news lands.

In 6 months time, zoomed out, this week will not be seen. Let alone every minute! The chart in 6 months time will be an order higher than it is today.

He could repeat that, but it’s been overdone in two Vox chats. Doing it again wouldn’t work out well, and the new investor community wouldn’t look twice. Their homework would tell them that. That coupled with recent sentiment draining from ‘Covid stocks’...

There’s every chance CV doesn’t land, and your script plays out, PL. let’s face it, history says that’s more likely. But now would not be the time. And my belief is we’ll have a fruitful run in to that presentation.

You’ve hit the nail on the head Mikey. A platform like that is to attract new money. The platform should be set with the publicity we should get in the next week.

Fancy publicly declaring you have the best performing asymptomatic test in the world. The only one that has been validated to be used in the home setting. That’s some stage he’s setting.

That’s better some optimism.

Investments are always dynamic. This one, has so much upside, the delays are acceptable to the majority. But they exist, no denying that.